Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Sexually Transmitted Diseases

  Free Subscription


2 Am J Obstet Gynecol
6 Cancer
1 Lancet Infect Dis
1 Oral Oncol
3 PLoS One
1 Science
1 Sex Transm Infect

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Obstet Gynecol

  1. HUH WK, Guido R
    Transitioning from HPV 101 to HPV 202.
    Am J Obstet Gynecol. 2017;216:206-207.
    PubMed     Text format    

  2. DILLEY S, Scarinci I, Kimberlin D, Straughn JM Jr, et al
    Preventing HPV-Related Cancers - We Are All In This Together.
    Am J Obstet Gynecol. 2017 Feb 21. pii: S0002-9378(17)30299.
    PubMed     Text format     Abstract available


  3. PATEL MA, Blackford AL, Rettig EM, Richmon JD, et al
    Rising population of survivors of oral squamous cell cancer in the United States.
    Cancer. 2016;122:1380-7.
    PubMed     Text format     Abstract available

    The impact of HPV testing for oropharyngeal cancers: Why the addendum matters.
    Cancer. 2017 Feb 27. doi: 10.1002/cncy.21842.
    PubMed     Text format    

    Human papillomavirus detection in a "Digital" age.
    Cancer. 2016;122:1502-4.
    PubMed     Text format    

  6. BIRON VL, Kostiuk M, Isaac A, Puttagunta L, et al
    Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Cancer. 2016;122:1544-51.
    PubMed     Text format     Abstract available

  7. CRACCHIOLO JR, Baxi SS, Morris LG, Ganly I, et al
    Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
    Cancer. 2016;122:1523-32.
    PubMed     Text format     Abstract available

  8. REUSCHENBACH M, Pauligk C, Karbach J, Rafiyan MR, et al
    A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
    Cancer. 2016;122:1425-33.
    PubMed     Text format     Abstract available

    Lancet Infect Dis

  9. DE JONG Y, Haverkort ME, van Sorge AJ, Jansen C, et al
    A translucent vascularised iris granuloma in a patient with secondary syphilis.
    Lancet Infect Dis. 2017;17:255-256.
    PubMed     Text format    

    Oral Oncol

  10. PORCEDDU SV, Milne R, Brown E, Bernard A, et al
    Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy.
    Oral Oncol. 2017;66:81-86.
    PubMed     Text format     Abstract available

    PLoS One

  11. GALEA JT, Monsour E, Nurena CR, Blas MM, et al
    HPV vaccine knowledge and acceptability among Peruvian men who have sex with men and transgender women: A pilot, qualitative study.
    PLoS One. 2017;12:e0172964.
    PubMed     Text format     Abstract available

  12. GALLO VAULET L, Grillova L, Mikalova L, Casco R, et al
    Molecular typing of Treponema pallidum isolates from Buenos Aires, Argentina: Frequent Nichols-like isolates and low levels of macrolide resistance.
    PLoS One. 2017;12:e0172905.
    PubMed     Text format     Abstract available

  13. AUDIRAC-CHALIFOUR A, Torres-Poveda K, Bahena-Roman M, Tellez-Sosa J, et al
    Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study.
    PLoS One. 2016;11:e0153274.
    PubMed     Text format     Abstract available


    Vaccine trust and the limits of information.
    Science. 2016;353:1207-8.
    PubMed     Text format    

    Sex Transm Infect

  15. RAMADHANI HO, Liu H, Nowak RG, Crowell TA, et al
    Sexual partner characteristics and incident rectal Neisseria gonorrhoeae and Chlamydia trachomatis infections among gay men and other men who have sex with men (MSM): a prospective cohort in Abuja and Lagos, Nigeria.
    Sex Transm Infect. 2017 Feb 24. pii: sextrans-2016-052798.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.